Cargando…
Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study
BACKGROUND: Urothelial bladder cancer (UBC) is a disease that often is discovered when the tumour is non-muscle invasive, i.e. in Ta or T1 stage. Some patients will progress into muscle-invasive disease, a potentially deadly condition. Although there are some prognostic models, the need for prognost...
Autores principales: | Boman, Karolina, Andersson, Gustav, Wennersten, Christoffer, Nodin, Björn, Ahlgren, Göran, Jirström, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348745/ https://www.ncbi.nlm.nih.gov/pubmed/28293425 http://dx.doi.org/10.1186/s40364-017-0090-y |
Ejemplares similares
-
Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
por: Andersson, Gustav, et al.
Publicado: (2014) -
Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker
por: Wennersten, Christoffer, et al.
Publicado: (2014) -
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
por: Boman, Karolina, et al.
Publicado: (2013) -
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013) -
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer
por: Andersson, Nina, et al.
Publicado: (2020)